Britain's largest drugmaker GlaxoSmithKline may be prosecuted in the United Kingdom under the country's anti-commercial bribery law.

 

　　The company is already facing bribery charges in China, after four of its senior executives in its Chinese sector detained by police.

 

　　Monty Raphael, special counsel in Business Crime in London, said GSK is at risk of being prosecuted in the UK, if the bribery conduct took place after July 1st, 2011, when UK adapted its relevant laws.

 

　　However, he also said that it is very likely the UK's judicial department will not prosecute GSK, due to fears that it may impact the country's economy, tax and employment.